EUVIMEDEUVIMED entdecken
Open Access

The Critical Importance of Clinical Use Case to Inform Point-of-Care Technology Development: A Case Study of HIV Nucleic Acid Assays in the United States

Yukari C Manabe iD, Matthew M Hamill iD, Kara M Palamountain iD, Chad J Achenbach, Kevin P Delaney, Yu-Hsiang Hsieh iD, Joyce L Jones iD, Rebecca P Kirby iD, Sally M McFall iD, William O Osburn iD, Stuart C Ray iD, Richard E Rothman und 2 weitere

Clinical Infectious Diseases · 2026

DOI: 10.1093/cid/ciaf510 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Infectious Diseases, 2026. Verfasst von Yukari C Manabe und 13 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: HIV Infections, Point-of-Care Testing, Point-of-Care Systems, Nucleic Acid Amplification Techniques. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NIH HHS, HIV Prevention Trials Network.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In global settings, both the clinical use case and value proposition have been well articulated. This has led to the development of many point-of-care (POC) diagnostics for infectious diseases. However, in the United States, more than 80% of infectious disease diagnostics are performed in reference laboratories that have high throughput but relatively long turnaround times. As the cost of POC assays has decreased with nucleic acid test (NAT) innovation catalyzed by the coronavirus disease 2019 pandemic, we sought to develop clinical use cases for human immunodeficiency virus (HIV) NATs and the technical specifications that would tip the value proposition toward commercialization and meaningful adoption. Without POC HIV NATs, we are unlikely to achieve our collective goal of HIV elimination in the United States.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsPoint-of-Care TestingPoint-of-Care SystemsNucleic Acid Amplification TechniquesHumansUnited StatesCOVID-19SARS-CoV-2RNA, ViralMolecular Diagnostic Techniques

Stichwörter der Autor:innen

HIVclinical use casediagnosticspoint-of-caretechnical product profile

Substanzen

RNA, Viral

Autor:innen und Institutionen

  • Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Kellogg School of Management, Northwestern University, Evanston, Illinois, USA.
  • Division of Infectious Diseases, Department of Medicine, Havey Institute for Global Health, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
  • US Centers for Disease Control, Atlanta, Georgia, USA.
  • Department of Emergency Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Center for Innovation in Point-of-Care Technologies for HIV/AIDS at Northwestern University, Evanston, Illinois, USA.

ORCID-Profile: Yukari C Manabe, Matthew M Hamill, Kara M Palamountain, Yu-Hsiang Hsieh, Joyce L Jones, Rebecca P Kirby, Sally M McFall, William O Osburn, Stuart C Ray, Joanne D Stekler

Förderung

  • NIAID NIH HHS
  • NIH HHS
  • HIV Prevention Trials Network
  • NCHHSTP CDC HHS
  • NIBIB NIH HHS
  • Johns Hopkins University
  • University of Washington
  • CDC HHS

Zitieren

APA

Manabe, Y. C., Hamill, M. M., Palamountain, K. M., Achenbach, C. J., Delaney, K. P., Hsieh, Y. H., Jones, J. L., Kirby, R. P., McFall, S. M., Osburn, W. O., Ray, S. C., Rothman, R. E., Stekler, J. D., & Katz, D. A. (2026). The Critical Importance of Clinical Use Case to Inform Point-of-Care Technology Development: A Case Study of HIV Nucleic Acid Assays in the United States. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciaf510

Vancouver

Manabe YC, Hamill MM, Palamountain KM, Achenbach CJ, Delaney KP, Hsieh YH, et al. The Critical Importance of Clinical Use Case to Inform Point-of-Care Technology Development: A Case Study of HIV Nucleic Acid Assays in the United States. Clinical Infectious Diseases. 2026. doi:10.1093/cid/ciaf510

BibTeX
@article{Manabe2026,
  author = {Manabe, Yukari C and Hamill, Matthew M and Palamountain, Kara M and Achenbach, Chad J and Delaney, Kevin P and Hsieh, Yu-Hsiang and Jones, Joyce L and Kirby, Rebecca P and McFall, Sally M and Osburn, William O and Ray, Stuart C and Rothman, Richard E and Stekler, Joanne D and Katz, David A},
  title = {The Critical Importance of Clinical Use Case to Inform Point-of-Care Technology Development: A Case Study of HIV Nucleic Acid Assays in the United States},
  journal = {Clinical Infectious Diseases},
  year = {2026},
  doi = {10.1093/cid/ciaf510}
}
Kostenlos starten →